Vol 15, No 2 (2025)
EDITORIAL
Scientific writing for biomedical journal



REVIEWS
Monkeypox outbreaks: a comprehensive review of epidemiology, clinical management, and public health responses
Abstract
Monkeypox, caused by a zoonotic virus, and has emerged as a significant public health issue, particularly with recent outbreaks extending beyond its traditional endemic areas in Central and West Africa. This virus, which belongs to the Orthopoxvirus genus, is closely related to the variola virus that causes smallpox. The resurgence of monkeypox underscores the urgent need to understand its epidemiology, clinical management, and public health responses, especially given the global spread observed in 2022. Monkeypox primarily transmits from animals to humans, with rodents and monkeys acting as the primary reservoirs. Secondary human-to-human transmission occurs through respiratory droplets or contact with contaminated materials. Clinically, monkeypox manifests with symptoms similar to smallpox, such as fever, rash, and lymphadenopathy, although it is generally less severe. Supportive treatments, including antivirals like tecovirimat, have shown efficacy in alleviating symptoms and reducing disease severity. Additionally, the development of new antiviral agents and treatment protocols remains an area of active research. Vaccination plays a crucial role in managing monkeypox outbreaks. The smallpox vaccine, which provides cross-protection against monkeypox, has been instrumental in controlling the spread of the disease. Public health strategies have emphasized targeted vaccination campaigns, thorough contact tracing, and comprehensive surveillance efforts. These measures highlight the necessity of rapid and coordinated actions to manage and prevent outbreaks effectively. Addressing the global burden of monkeypox requires strengthening healthcare infrastructure, enhancing disease surveillance systems, and fostering international collaboration. Efforts to improve diagnostics, vaccine distribution, and public health education are also vital. By focusing on these areas, the global community can improve its capacity to manage and mitigate the impact of this re-emerging infectious disease. Effective response strategies are essential for controlling current outbreaks and preventing future ones, ultimately reducing the global impact of monkeypox and improving public health outcomes.



New approaches for combating polyresistant ESKAPE pathogens
Abstract
Antibiotic resistance of microorganisms is the most pressing global health problem due to the ever-increasing number of deaths caused by ineffective antibiotic therapy. The COVID-19 pandemic has only exacerbated pre-existing issue of increasing resistance of bacterial strains worldwide. Lack of public awareness about proper use of antibiotics directly impacts on uncontrolled antibiotic administration associated with weak antibiotic dispensing controls as well as limited access to health facilities in low- and middle-income countries. It is reported that 68.9% of COVID-19 patients used antibiotics for prophylaxis against bacterial complications or to treat coronavirus infection (mainly azithromycin and ceftriaxone) before hospitalization, with a self-medication rate of 33.0%. The most antibiotic-resistant and dangerous to global public health group of microorganisms is known as ESKAPE: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species. The proportion of resistant strains among these microorganisms can reach 95%. In light of the rapid increase in the number of infections caused by antibiotic-resistant strains, a need to create new antibacterial drugs is the most urgent task. The development of new antibiotics is a high-cost goal and it’s often ineffective. Therefore, more and more often their developers resort to the use of antibiotics combinations or using them together with adjuvants of different mechanisms of action. In recent years, special devices and coatings with nanoparticles of various metals deposited on their surface have become increasingly widespread. Some successes achieved in the use of antimicrobial peptides have been leveled by the loss of activity in the human body and their high production cost. In this regard, the use of bacteriophages, especially in combination with antibiotics, has been becoming a promising approach. The observed synergism both in vitro and in vivo experiments allow to hope for certain successes in the fight against ESKAPE group multidrug-resistant pathogens.



Human papillomavirus in vulvar cancer: a systematic review
Abstract
Introduction. Being considered as one of the most difficult to cure, vulvar malignant neoplasms belong to rare oncopathologies of the female reproductive system. It is established that vulvar squamous cell cancer develops via two pathways. In the first scenario, the tumor may develop during vulvar dystrophic diseases such as scleroatrophic lichen and differentiated intraepithelial neoplasia. Another opportunity is directly related to HPV infection. Highly oncogenic HPV types are known to be associated with cervical carcinogenesis and are involved in developing vulvar, vaginal, and anal intraepithelial neoplasia, which are considered precursors to carcinomas. In recent decades, a rise in incidence of vulvar cancer developed after preceding degenerative processes was noted. A relationship between human papillomavirus and cervical cancer has long been known and confirmed, so an issue regarding a potential relation between the etiology of vulvar cancer and of HPV remains relevant. The aim of the paper is to systematize and analyze the study data on vulvar carcinogenesis related to HPV infection.
Materials and methods. A literature search was performed using PubMed, Web of Science and Google Scholar databases. A literature review was conducted by analyzing studies published between 1993 and 2024. The review included papers in which HPV was found in more than one case of vulvar tumor and if HPV DNA was detected by using polymerase chain reaction. Initially 249 articles were selected, 25 papers were included in the qualitative analysis, from which 6 case-control studies that fully met the specified inclusion criteria were further analyzed. Overall HPV prevalence was calculated as the percentage of all HPV tested cases.
Results. A high prevalence of papillomavirus infection in vulvar tumors was shown (31%), with HPV type 16 occurring in the vast majority of cases. The prevalence of HPV in vulvar tumors in case-control studies was 30% (OR = 10.46).
Conclusion. The results of the current systematic review confirmed that HPV infection is a key risk factor for developing vulvar malignancies. We demonstrated a high prevalence of HPV infection in vulvar tumors. In addition, a high incidence of highly oncogenic HPV types in tumor tissue was shown.



ORIGINAL ARTICLES
Phylogenetic characteristics and analysis of the antigenic epitopes of Russian rotaviruses in comparison with vaccine strains
Abstract
Accumulation of mutations in the amino acid sequence of immunologically significant regions of the outer capsid proteins in locally circulating rotaviruses may reduce the effectiveness of vaccine-generated protection. The aim of the work was to comparatively analyze Russian rotaviruses and strains of the Indian pentavalent vaccine approved for use in the Russian Federation in 2020.
Materials and methods. There were used 38 rotavirus-positive samples derived from children with acute intestinal infection identified in 2022–2023. cDNA fragments of the VP7 gene 877 bp long were sequenced by two strands using “Nanofor 05” device. Phylogenetic analysis was performed using BEAST software package. The final sample included 161 VP7 gene sequences of RVA isolates from three Russian cities (Nizhny Novgorod, Moscow, Novosibirsk), other countries, and vaccine strains.
Results. Based on the results of phylogenetic analysis, Russian rotaviruses were found to belong to 13 lineages and/or sublineages (G1-I-A, G1-II-C, G2-IVa-1, G2-IV-3, G3-I, G3-3-а, G3-3-е, G4-I-с, G6-I, G8-IV, G9-III-d, G9-VI-е, G12-III). Vaccine strains (D, WI79-9, A41CB052A, DS-1, SC2–9, P, WI78-8, ST3, BrB-9, WI79-4, AU-32, 116E) were grouped separately in each case (G1-III, G1-II-A, G2-I, G2-II, G3-3-d, G4-I-а, G6-IV, G9-I, G9-II). Comparative analysis in the regions of antigenic epitopes targeted by neutralizing antibodies showed 3 to 6 amino acid differences between Russian and homotypic vaccine strains. The highest number was observed in isolates of sublineages G1-I-A, G2-IVa-1 and lineage G3-I. In the regions of T-cell epitopes, 1 to 4 substitutions were found. The greatest number of differences had rotaviruses of the G3-I lineage and the G4-I-c sublineage.
Conclusion. For the G3P[8] variant of the G3-I lineage, which is widespread in Russia, 6 substitutions in neutralizing epitopes and 4 substitutions in T-cell epitopes were found in comparison with homotypic vaccine strains. The study results are important for understanding a potential impact of vaccines on the antigenic structure of the rotavirus population in Russia.



Type profile of high oncogenic risk human papillomavirus in clinical forms of cervical infection in Russian Federation
Abstract
Aim: To establish a relationship between the clinical forms of cervical papillomavirus infection and the specific characteristics of high-risk human papillomavirus (HPV) types. The study included 1063 patients aged 16 to 71 years (Me = 33; IQR: 29–38) with active papillomavirus infection and its clinical forms. The patients were stratified into groups based on disease clinical forms during active HPV infection: carriers, mild cervical intraepithelial neoplasia, moderate cervical intraepithelial neoplasia, severe cervical intraepithelial neoplasia, carcinoma in situ, and invasive cervical cancer. Diagnostics was performed using real-time polymerase chain reaction (PCR) with HPV typing (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68). The results demonstrated that viruses from the alpha-phylogenetic branch are responsible for developing clinical forms of HPV infection. It was found that severe forms of infection, including cervical cancer, was mainly linked to A9 family (HPV16, HPV31, HPV58) viruses, whereas initial disease stages — to A5 and A6 families (HPV51 and HPV66). A particularly significant observation is the transition from A5, A6, and A7 family HPV viruses with relation to HPV16, to the A9 family showing highly related to HPV16. This observation underscores the high significance of HPV16 monoinfection in cervical cancer within the context of the replication theory for HPV16-like viruses. Viral load exhibits a wave-like pattern depending on the clinical form and HPV family, indicating the dynamic nature of the infection process and the potential changes in viral load based on the disease stage and virus type. The study highlights the importance of identifying a specific HPV type in mono- or polyinfection to assess disease clinical form. This can provide significant aid to clinicians for assessing severity of the infection and devising the appropriate management strategy for patients. In conclusion, our findings emphasize a need to take into consideration a HPV type in diagnostics and treatment of cervical papillomavirus infection. This approach will enhance prognostic accuracy and effectiveness of therapeutic interventions aimed at preventing disease progression and cervical cancer development.



Epidemiological features of viral hepatitis C in the Tomsk region
Abstract
Introduction. Despite the great advances made in the field of virology and their diagnostics, a number of difficulties affect improvements in the control and elimination of hepatitis C virus (HCV) infection at present. New cases of HCV infection still occur worldwide, including Tomsk Region (TR). The aim of the study was to analyze the epidemiological situation with regard to acute and chronic forms of HCV in adults and children for the period 2022–2023, and the structure of morbidity in TR.
Materials and methods. The features of the HCV epidemic process were assessed using official data presented in the State Report “On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2023”, statistical reporting form No. 2, federal statistical surveillance form No. 65 “Information on chronic viral hepatitis” form 065 for the period of 2023, quarterly reports of regions to the Ministry of Health of the Russian Federation within the framework of the implementation of measures aimed at combating HCV infection in 2021–2030.
Results. In TR, stable incidence rates of first-time detected forms of chronic viral hepatitis have been registered over the last years: in 2023 — 18.82 cases of chronic hepatitis C per 100 thousand population, in the population of children — 11.2 cases per 100 thousand population. Indicators of HCV morbidity in the TR indicate a tendency towards the spread of HCV infection in all age groups with an increase in the age limit. Genotypic diversity of HCV infection in the TR in 2023 is represented by subtypes 1a, 1b, 2, 3a/3b. The planned coverage of antiviral therapy in 2024 cannot significantly affect the epidemiologic situation on HCV in TR and achieve the results of elimination by 2030 and requires annual increase of funding.
Conclusion. The incidence rate of HCV infection in the TR is 1.7 times lower than the all-Russian one. Low level of HCV prevalence in the pediatric population in the TR made it possible to carry out micro-elimination of HCV among children. Insufficient level of HCV genotypes determination requires increasing the coverage of genotyping for epidemiologic surveillance in each region.



Assessment of collective immunity to enteric hepatitis viruses in the Kyrgyz population
Abstract
The problem of viral hepatitis A (HA) and E (HE), has remained relevant for many decades. According to estimates by the World Health Organization, millions of people are exposed annually to the risk of infection with these hepatitis A (HAV) and E (HEV) viruses. Because HA and HE can be asymptomatic, their true prevalence is very difficult to estimate. The aim was to assess seroprevalence of HAV and HEV infections in the Kyrgyz Republic, taking into account the infectious and vaccination status and socio-demographic characteristics of volunteers.
Materials and methods. The cohort under examination comprised 6610 apparently healthy individuals (volunteers) aged from 1 to 70+ years residing in the Kyrgyz Republic. The questionnaire included the collection of personal data, information on chronic diseases, blood transfusions, and surgical interventions, as well as specific information on each type of infection considered in the study, including data on past cases of hepatitis A and E, and vaccination against hepatitis A. ELISA analysis for HA and HE marker presence involved anti-HAV IgG, and anti-HEV IgG qualitative determination (test-systems by Vector-Best, and Diagnostic Systems RPC).
Results. During the study, anti-HAV IgG antibodies were detected for 76.8% of cases, and anti-HEV IgG antibodies were detected for 5.6% of cases. The seroprevalence rate for HAV and HEV was higher among women than among men. A direct correlation was shown between the occurrence of anti-HAV IgG and anti-HAV IgG with the age of the volunteers. Anti-HAV IgG was found in 75.4% of individuals denying hepatitis A history, while anti-HEV IgG was detected in 5.6% of those denying hepatitis E history. The share of vaccinated against HAV individuals was 5.9%. During the study, an assessment of the prevalence of markers for HA and HE in the population per 100 000 inhabitants was conducted, which resulted in 76.030 cases per 100 000 for HA, and 5567 cases per 100 000 for HE.
Conclusion. The need is obvious continuing nationwide vaccination initiatives against hepatitis A, expanding mandatory vaccination coverage for vulnerable groups, conducting additional evaluations of existing preventive measures, launching educational campaigns focused on HA and HE prevention strategies.



The etiological profile and alterations in cerebrospinal fluid characteristics in patients with bacterial meningitis
Abstract
Currently, bacterial meningitis (BM) remains a form of life-threatening infectious pathology, with a mortality rate ranging from 4% to 35% and poor prognosis often accompanied by diverse specific and non-specific complications, including infectious toxic shock, cerebral edema, ventricular inflammation, hydrocephalus, acute cerebrovascular accidents, venous sinus thrombosis, disseminated intravascular coagulation (DIC) syndrome, respiratory distress syndrome (RDS) syndrome, inappropriate secretion of antidiuretic hormone, and systemic inflammatory response syndrome. In clinical practice, the early identification of the causative microorganism and the implementation of proper antibiotic treatment, as well as a comprehensive assessment of the patient’s status and management, are crucial for minimizing a risk of related severe complications and mortality. The BM etiology is characterized by a highly variable nature, contingent upon a multitude of factors such as geographic location, temporal context, patient age, immunological status, and other variables. Over the past two to three decades, advancements in conjugate vaccines and the use implementation of antibiotic treatment have brought about alterations in the spectrum of pathogens responsible for meningitis. The objective of this study was to delve into the etiological profile and prognostic implications of cerebrospinal fluid (CSF) parameters among patients with diagnosed meningitis admitted to the Neuroinfectious Diseases Division of the Infectious Clinical Hospital No. 2 (Moscow) between 2022 and 2023. A retrospective analysis of medical records of meningitis patients admitted to the Infectious Clinical Hospital No. 2 during 2022–2023 was conducted. The data were analyzed using the k-means clustering algorithm implemented in the Loginom analytics software to create a scenario, as well as OLAP cubes. The study involved the analysis of medical records for 110 patients aged 18–89 years old. Among the BM pathogens identified, Neisseria meningitidis emerged as the most prevalent in this patient cohort, accounting for 68.2% of cases. Within the group of meningococcal meningitis cases, serovariants A and W135 were the most frequently detected, accounting for 49.3% and 33.3%, respectively. Significant alterations in cerebrospinal fluid parameters, characterized by elevated cell counts and lowered glucose levels, were observed among patients with purulent meningitis resulting from serogroup A Neisseria meningitidis infections. A combination of elevated baseline cell level along with high concentrations of proteins, and lactate, coupled with the presence of D-dimer in cerebrospinal fluid, has been associated with a severe disease progression and the emergence of critical and life-threatening sequelae.



Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatic approach
Abstract
Background. An outbreak of SARS-CoV-2 in 2019 has brought a great challenge to public health and rapid identification of immune epitopes for designing an effective vaccine for different variants of SARS-CoV-2 is necessary at the time of the pandemic. Rational, rapid, and precise vaccine design, especially vaccine antigen identification and optimization by in silico methods of bioinformatics, structural biology, and immunoinformatic is critical to efficient vaccine development against the SARS-CoV-2 virus. The aim of this study was to develop a particular novel and effective vaccines vaccine using bioinformatics approaches and resources that can target B- and T-cell epitopes to combat SARS-CoV-2 infection.
Materials and methods. The variants of SARS-CoV-2 (Alpha, Beta, Delta, and Omicron strains) spike protein were selected for designing the vaccine. The B-cell, T-cell, and IFNg-inducing epitopes were predicted. The beta-defensin-3 protein was selected as adjuvant and predicted epitopes were connected using suitable linkers. The vaccine’s allergenicity, antigenicity, physicochemical characteristics, 2D and 3D structure modeling, and molecular docking were evaluated for the final construct.
Results. The in silico results showed that the multi-epitope vaccine has a stable structure and can induce humoral and cellular immune responses against SARS-CoV-2.
Conclusion. B-cell and T-cell epitopes on spike protein were identified and recommended for design and confirmation of in vivo evaluation for multi-epitope peptides as vaccines against SARS-CoV-2.



Characteristics of the blood plasma “lipid peroxidation — antioxidant protection” system depending on nasal mucosa microflora composition in various chronic rhinitis phenotypes
Abstract
Chronic rhinitis is the most common ENT disease. Over the past decade, there has been an increased incidence of chronic rhinitis. In all forms of chronic rhinitis, there is a decrease in the protective properties of nasal mucous membrane, which can be accompanied by activation of nasal bacterial microflora. Dysbiosis of nasal mucous microbiota contributes to the development of inflammation, activation of immune cells with the development of immune reactions, activation of lipid peroxidation processes and changes in the activity of antioxidant defense factors in nasal cavity and blood. There is evidence that different phenotypic variants of chronic rhinitis are characterized by own specific spectrum of microorganisms in the nasal cavity, which significantly affects the course of diseases, as well as the state of the lipid peroxidation — antioxidant protection (LPO–AOP) system. The aim of our work was to comparatively assess quantitative composition of the microbial flora and indicators of the LPO–AOP system in patients with various forms of chronic rhinitis. The article presents the results of a laboratory examination of 165 patients with chronic rhinitis, including 45 patients with chronic allergic rhinitis, 49 patients with chronic vasomotor rhinitis, 32 patients with chronic atrophic rhinitis, and 39 patients with chronic infectious rhinitis. The control group consisted of 40 apparently healthy donors. In accordance with the study design, at the first stage, all subjects underwent a bacteriological examination of nasal mucous membrane and a quantitative assessment of the isolated microflora representatives. At the second stage, the LPO–AOP indices were determined in the blood plasma using a spectrophotometric method. Statistical analysis of the obtained results was performed using the Statistica 8.0 software package. To assess differences in the groups, the Kruskal–Wallis, Mann–Whitney, and Wilcoxon nonparametric tests were used. The critical level of statistical significance for testing scientific hypotheses was considered equal to p < 0.05. The data are presented as a median (Me) and interquartile range (Q25–Q75). Changes in nasal mucosa microbiome induce a decrease in the activity of antioxidant defense factors in all studied phenotypic forms of chronic rhinitis. In cases of chronic allergic, vasomotor and infectious rhinitis, a significant increase in the level of both primary and secondary lipid peroxidation products is observed. Studies show that the greatest increase in lipid peroxidation activity is recorded in chronic infectious rhinitis, as well as the greatest nasal mucosa dysbiosis is revealed in this phenotype. Thus, the leading pathogenetic mechanism in chronic rhinitis is presented by hypoxia due to intermittent nasal congestion, which contributes to changes in the LPO–AOP system. At the same time, activated microbial flora also contributes to aggravation of such changes.



The effects of valacyclovir on polyomavirus infection (BKV) in kidney transplant recipients
Abstract
Polyomavirus-associated nephropathy (PVAN) is one of the most serious infectious complications in allograft recipients, with the BK virus (BKV) being the primary etiologic agent. This study was conducted to investigate the efficacy of valacyclovir on BK virus (BKV) infection and viremia control in infected patients in Iran. This quasi-experimental study involved 21 Iranian patients. All kidney transplant recipients with a confirmed diagnosis of BKV infection based on renal biopsy and PCR were administered standard therapy (reduced doses of immunosuppressive drugs) with or without valacyclovir at a one-gram dose twice daily for one month. After collecting the data, the data was analyzed using SPSS 23. The K-S test confirmed the normality of the quantitative data. Chi-square for trend, independent-t, and Fisher’s exact tests were used to examine group homogeneity in terms of socio-demographic characteristics. Before the intervention, a t-test was used to compare mean scores among the groups; and repeated measures independent sample test, pair sample test, chi square test and ANOVA. The significance level of p < 0.05 was considered for all tests. The mean creatinine level, mean GFR (Glomerular Filtration Rate) level, and median viral load in the serum were not significantly different between the two groups at the time of graft rejection diagnosis. One month after treatment, the serum viral load decreased in 90.9% of patients in the intervention group and 50% of patients in the control group, with the difference being statistically significant (p = 0.038). Also, in the two-month review, the results showed that the reduction of the virus serum load level was observed in 81.8% of patients in the intervention group and 40% of patients in the control group, and this difference was statistically significant (p = 0.049). Mean age, body mass index, and transplant duration were comparable between the two groups. Neither creatinine nor GFR levels differed significantly between the two groups after the intervention (p = 0.557 and p = 0.387). Valacyclovir can effectively reduce the serum viral load in BKV-infected kidney transplant recipients. This reduction, however, is not accompanied by an improvement in renal function or prevention of rejection.



Dynamics of alterations in white blood cell and sepsis-associated humoral factors during sulfur mustard intoxication
Abstract
Introduction. Sulfur mustard (SM) is an important chemical warfare agent. Lack of antidote and pathogenetic means in the arsenal of modern medicine for the treatment of SM poisoning requires further studies on the pathogenesis and development of protective medical devices and treatment schemes. The aim is to assess the features of immune response and intestinal bacterial translocation during SM intoxication. Materials and methods. The experiments were performed with Chinchilla male rabbits. SM was injected to laboratory animals intramuscularly at a dose of 63 mg/kg, amounting to 1.0 LD84. The test materials presented by blood samples collected by cardiac puncture and from the lateral ear vein. Cardiac blood was used to produce serum and subsequently to determine the level of the sepsis-associated humoral factors (lipopolysaccharide, sCD14, procalcitonin, TNFa, IL-6, IL-10) by using enzyme-linked immunosorbent assay. Results. In the peripheral blood of rabbits there were found changes characterized by decreased total leukocyte count, a development of lymphocytopenia and monocytopenia, as well as two-phase granulocyte count dynamics. The blood leukocyte formula showed the most significant changes related to three cell subsets: segmentonuclear neutrophils, lymphocytes and plasmocytes. The analysis of blood serum for assessing level of the sepsis-associated humoral factors showed that the earliest pathobiochemical change was related to higher sCD14. On day 2 post-exposure, a simultaneous increase in the levels of TNFa, IL-6, IL-10 was reported. The cytokine level was decreasing to baseline range starting from day 3 onwards, whereas the clinical manifestation of SM intoxication was increasing and reaching the maximum magnitude. The analysis of blood serum for lipopolysaccharide level showed its increase on day 3 and 4 post-exposure. Conclusion. The study data in the context of the proposed interpretation, allow to highlight the following phasing of pathological changes during an extremely severe SM intoxication: day 1 — myeloid phagocytic system activation and hyperphagocytosis; day 2 — systemic inflammatory and compensatory anti-inflammatory response syndromes; days 3–4 — “immune paralysis”, intensified bacterial translocation, depletion of the endotoxin-binding system and “endotoxin aggression”.



SHORT COMMUNICATIONS
Some aspects of prevalence and intrafamilial transmission of Helicobacter pylori among population of the Republic of Armenia
Abstract
Helicobacter pylori (HP) continues to be a serious public health issue worldwide, causing significant morbidity and mortality due to peptic ulcer disease and stomach cancer. This study was conducted to investigate the prevalence and intrafamilial transmission of HP infection among the population of Armenia. Materials and methods. In this study, the immunochromatographic method was used to detect HP microorganisms in stool samples. Results. The average age of the patients tested for HP was 29.9±2.0 years, with an age range from 2 months to 75 years. The study included 316 female patients, of whom 37.7% (95% CI: 32.4–43.0) tested positive for HP microorganisms, and 180 male patients, of whom 39.4% (95% CI: 32.3–46.5) tested positive. The highest prevalence of infection was observed in the following age groups: 50–59 years (65.1%), 40–49 years (47.1%), 30–39 years (41.1%), 20–29 years (40.4%), and 60–69 years (40.0%). Conclusion. Our research on patients with inflammatory diseases of the upper gastrointestinal tract, their family members, and others revealed a high infection rate of HP across all age groups. The study demonstrated a significant prevalence of HP infection among the population of Armenia, indicating a high likelihood of intrafamilial transmission.



Dynamic observation of upper airways colonization in a cystic fibrosis patient infected with Roseomonas aerofrigidens under targeted therapy
Abstract
Cystic fibrosis (CF) is a disease characterized by a varying microbiological diversity, including bacteria such as Pseudomonas aeruginosa, Burkholderia cepacia complex, Achromobacter xylosoxidans/ruhlandii. Additionally, there are microorganisms with unknown clinical significance, including Roseomonas aerofrigidens. The main goal of the study is to evaluate the prevalence of such microorganisms among CF patients undergoing regular examinations at the microbiological laboratory of the Samara State Medical University, Ministry of Health of the Russian Federation. An analysis of 12 094 clinical material cultures was carried out, with identification done by using MALDI-ToF mass spectrometry. A composite correlation index was calculated. The Jaccard similarity coefficient was used to assess the nature of symbiotic or antagonistic interactions. A total of 20 strains of Roseomonas spp. bacteria was isolated. Four strains were obtained from the mucous membrane of the posterior pharyngeal wall, while the remaining strains — from nasal lavage fluid. The patient with F508del/F508del genetics had been receiving dual targeted therapy since October 2022. Before treatment, no clinically significant Gram-negative species or Roseomonas aerofrigidens strains were noted in the patient’s anamnesis. However, during observation, Roseomonas aerofrigidens cultures were obtained from nasal lavage fluid at the third, fifth, sixth, eighth, ninth, eleventh, and eighteenth months of observation, with no concurrent bacterial strain growth in sputum samples. The study of the protein profiles demonstrated a high degree of kinship among the isolates, with a correlation index exceeding 0.8, confirming the hypothesis on long-term colonization of the paranasal sinuses by same Roseomonas aerofrigidens strain. While assessing the consistency criterion, it was found that among 30 microbial species isolated from nasal lavage fluid over 18-month observation, two microorganisms were classified as representatives of the constant microbiota, four (including Roseomonas aerofrigidens) as additional microbiota. The remaining species belong to random microbiota. Based on the Jaccard coefficient, it was found that four pairs of microorganisms are characterized by a synergistic nature of the relationship. These observations demonstrate a case of multi-month colonization with a unique strain of Roseomonas aerofrigidens in a patient with cystic fibrosis receiving targeted therapy.



Surgical site infection in HIV-positive patients with chronic spondylitis
Abstract
Introduction. The epidemic process of medical care-related infections complies to the general laws for development of epidemic process, although it has specific features. The probability for development of surgical site infection becomes precipitated by risk factors, which contribute to emergence of surgical site infection based on traits of pathology, patient populations and the specifics of hospital facility. The aim of the study was to evaluate HIV-related effect on developing surgical site infection in patients with chronic spondylitis. Materials and methods. A retrospective cohort epidemiological study was conducted. The inclusion criteria were met by 809 examined patients including 119 HIV-positive patients who underwent 192 surgical interventions. At admission, a patient provided a discharge summary describing the disease profile as well as HIV-positive status verified by infectious disease specialist through a comprehensive data assessment, no more than a month prior to admission. HIV-infected and HIV-free patients comprised exposed and unexposed cohort, respectively. Results. Tuberculous spinal lesions prevailed in HIV patients (p ≤ 0.001; RR = 4.864; 95% CI [3.070–7.707]). Almost all patients were at stage 4 HIV, and one patient — stage 3. The incidence of surgical site infection in patients with chronic infectious spondylitis was 5.01 per 100 operations (49 cases per 978 operations), in HIV patients it developed only in 2 cases of tuberculous spondylitis (the incidence was 1.04 per 100 operations). HIV-infection did not increase the risk of surgical site infection (p = 0.009; RR = 0.174; 95% CI [0.043–0.711]. Surprisingly, it turned out to observe higher risk of revision interventions in HIV-free patients (p = 0.007; RR = 1.783; 95% CI [1.149–2.768]). Conclusion. HIV-positive patients had higher risk of developing a tuberculous than a nonspecific lesion. The HIV status of patients with chronic infectious spondylitis did not significantly affect development of surgical site infection and increased incidence of revision operations. A potential reason for the final result is the long-term use of anti-tuberculosis drugs acting, in this case, as a preventive measure against developing surgical site infection.



The role of genetic hemostasis gene variants in the development of venous thrombosis in patients with atherosclerosis after COVID-19 infection
Abstract
Introduction. The new coronavirus infection (COVID-19) is one of the most important problems in modern medicine. One of the etiopathogenetic COVID-19 arms is presented by a disorder in the hemostasis system, which can be associated with emerging thrombosis of various localizations and altered vascular circulation in small vessels. But coagulation disorders can be pathogenetically associated with atherosclerotic processes in the vascular bed, which can be activated as early as at age of 35–40 years. Therefore, it is relevant to study the genetic factors between COVID-19 etiopathogenetic relation and thrombogenic and atherosclerotic pathological processes. Purpose of the study. To establish a relation between previous COVID-19 infection and risk of venous thrombosis caused by 8 genetic variants ((F2 20210G>A, F5 1691G>A, F7 10976G>A, F13 G>T, ITGA2 807C>T, ITGB3 1565 T>C, PAI-1 -675 5G>4G) in the coagulation system genes in patients with atherosclerosis. Materials and methods. The study included 172 patients aged 30 to 55 years with signs of atherogenic vascular lesions, who had episodes of venous thrombosis of various localizations within a year after clinically manifested COVID-19, confirmed by molecular genetic diagnostics of SARS-CoV-2, and 151 COVID-19 convalescent patients aged 30 to 54 years (comparison group), without episodes of venous thrombosis. Molecular genetic analysis of genetic variants of the hemostasis system genes was performed by real-time PCR with automated melting curve analysis. Results. According to the results of the association analysis of genetic variants with venous thrombosis in COVID-19 convalescent patients, a relation was established for 2 genetic variants, ITGA2 807C>T (TT OR = 5.59 (СI: 2.86–10.93, p < 0.001)) and ITGB3 1565 T>C (genotype CC, OR = 6.55 (СI: 2.23–19.22, p < 0.001)). Conclusion. Thus, we established an association between 2 genetic variants (ITGA2 807C>T and ITGB3 1565 T>C) and venous thrombosis in COVID-19 convalescent patients with atherosclerosis.



Method for phenotypic identification of Acinetobacter seifertii bacteria
Abstract
Abstract. The aim of the study is to increase the accuracy of Acinetobacter seifertii species identification by the phenotypic method. Study objects: 5 strains of A. seifertii (3 isolated in the microbiological laboratory at the Military Medical Academy, 2 strains obtained from the Pasteur Institute (St. Petersburg)). Clinical strains of the A. baumannii group (Ab group) isolated at the Military Medical Academy in 2023–2024 were also studied: A. baumannii (n = 152), of which 37 strains of the tryptophandestruens biovar, A. nosocomialis (n = 12), A. pittii (n = 6), 3 strains of A. calcoaceticus from the Neva River. The type of such strains was determined by MALDI-ToF mass spectrometry. The belonging of the strains to the Ab group was established by taxonomic tests. The biovar A. baumannii bv. tryptophandestruens was determined by a chromogenic reaction on sodium benzoate-containing nutrient medium. Urease of rapid activity was detected by a micro-volumetric method assessed 3 hours later. Utilization of D-xylose as the only carbon source was determined on a nutrient medium containing (g/l): D-xylose 2.0; NH4CI 5.0; NH4NO3 1.0; Na2SO4 2.0; K2HPO4 3.0; KH2PO4 1.0; MgSO4 0.1; bromothymol blue 1.6% aqueous solution 4 ml; bacteriological agar 15.0; distilled water 1 L; pH 7.2±0.2; sterilization at 112°C 20 min. A pure bacterial culture was studied, in which signs of the Ab group and growth on a sodium acetate-containing nutrient medium were previously detected (control of no auxotrophy). The agar bacteria culture was suspended in 0.1 ml of 0.85% sodium chloride solution, one loop of bacterial suspension was sown with a stroke on a nutrient medium with D-xylose and a medium without D-xylose (control), incubated aerobically at 30°C 24–48 hours. The absence of bacterial growth on a medium with D-xylose and a medium without D-xylose in the presence of their growth on a nutrient medium with sodium acetate indicates belonging to the species A. seifertii. Studies showed that all A. seifertii strains do not utilize D-xylose, and all strains of other species of the Ab group utilize D-xylose. A. seifertii bacteria do not utilize L-arabinose, however, 29.6±3.7% of A. baumannii strains do not utilize L-arabinose, including all 37 strains of the tryptophandestruens biovar, which determines the unreliability of this test for the identification of A. seifertii. Most strains of A. seifertii (4 out of 5) have a urease of rapid activity, which suggests their proximity to the species A. nosocomialis. A method has been developed for identification of A. seifertii bacteria based on a set of phenotypic features of Ab group bacteria with a test for D-xylose utilization. It has been established that the use of the D-xylose utilization test in conjunction with the detection of rapid urease activity allows to accurately identify the bacteria A. seifertii and A. nosocomialis among other species of the Ab group.



FOR THE PRACTICAL PHYSICIANS
Clinical case of cavernitis — complicated monkeypox infection
Abstract
The article presents a clinical case of monkeypox (MPOX) infection, a rare acute viral zoonosis until 2022, previously endemic in Africa, but currently recorded worldwide, including Europe and Bulgaria. The clinical case describes a 35-year-old man, healthy before the current disease, hospitalized to urology clinic with a diagnosis of cavernitis-complicated acute balanoposthitis. In the department, surgical treatment of liberatio cordi periglandularis penis was performed. The combination of intoxication syndrome with characteristic elements of pustular rash, initially treated as staphyloderma, served as the basis for infectious disease specialist to assume that the patient had MPOX, which was subsequently confirmed by using polymerase chain reaction (PCR) method, after which the patient was transferred to the infectious disease clinic for isolation and treatment, which included detoxication, antibiotic and analgesic therapy. Upon discharge, the patient observed the quarantine regime until all elements of the rash had completely healed, and one-month follow-up observation after discharge showed no deviations from the norm. Due to the presence of a urogenital complication, cavernitis, a rare for this infection, a multidisciplinary approach was required, including urologists, dermatologists and infectious disease specialists. The surgical, pathogenetic and symptomatic treatment led to the patient complete recovery. Although monkeypox-related urogenital complications are rare, they can occur, which requires increased attention to such atypical disease manifestations. MPOX is a rare viral disease that has attracted the attention of health professionals due to its increasing incidence in countries where it is not typically endemic. The key finding of the current study is the necessity for increased vigilance by professionals of various specialties to rare and emerging infectious diseases such as MPOX to control their spread.



OBITUARY
In memory of Kirill P. Kashkin


